novel transcript, antisense to dynein axonemal heavy chain 14 (ENSG00000298651)

This is a novel, natural antisense transcript (NAT) identified as an RNA sequence transcribed from the genomic region antisense to the dynein axonemal heavy chain 14 (DNAH14) gene[1][6]. Such antisense transcripts are typically classified as long non-coding RNAs (lncRNAs); they often do not encode proteins, but may be involved in regulating gene expression of the sense transcript (here, DNAH14) through mechanisms such as RNA interference, chromatin remodeling, or modulation of mRNA stability[6][8]. No direct evidence supports a specific biological function, disease association, or therapeutic potential for this transcript, and it is not currently considered a druggable gene product. The entry is correctly annotated in genomic resources as an uncharacterized antisense lncRNA, and substantial functional or structural characterization is lacking. If you require structured extraction or mapping to other databases, note that almost all known information is at the annotation level, rather than functional or therapeutic (i.e., it is not a characterized "receptor, enzyme, or similar protein-coding gene")[1][6][8].

Other names

LOC105373109novel transcript, antisense to DNAH14ENSG00000298651